home / stock / naut / naut news

NAUT News and Press, Nautilus Biotechnology Inc. From 09/23/22

Stock Information
Company Name: Nautilus Biotechnology Inc.
Stock Symbol: NAUT
Market: NASDAQ
Website: nautilus.bio
Menu
NAUT NAUT Quote NAUT Short NAUT News NAUT Articles NAUT Message Board
Get NAUT Alerts

News, Short Squeeze, Breakout and More Instantly...
NAUT - Nautilus Biotechnology to Participate in the Capital One Spatial Biology & Proteomics Summit

SEATTLE, Sept. 23, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced the company will be participating in the upcoming Capital One ...
NAUT - Nautilus Biotechnology Joins Human Proteome Organization (HUPO) Industrial Advisory Board

SEATTLE, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced it has joined the Human Proteome Organization (HUPO) Industria...

NAUT - Nautilus Biotechnology to Participate in the Morgan Stanley Global Healthcare Conference

SEATTLE, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced the company will be participating in the upcoming Morgan Stanle...

NAUT - Nautilus Biotechnology, Inc. (NAUT) CEO Sujal Patel on Q2 2022 Results - Earnings Call Transcript

Nautilus Biotechnology, Inc. (NAUT) Q2 2022 Earnings Conference Call August 02, 2022 08:30 AM ET Company Participants Sujal Patel - Founder and Chief Executive Officer Anna Mowry - Chief Financial Officer Parag Mallick - Founder and Chief Scientist Conferen...
NAUT - Quoin, Context top healthcare gainers; Ontrak, Phathom lead losers' pack

Gainers: Quoin Pharmaceuticals ( QNRX ) +45% . Context Therapeutics CNTX +13% . Rhythm Pharmaceuticals RYTM +13% . Harmony Biosciences HRMY +10% . Nautilus Biotechnology NAUT +9% . Losers: Ontrak OTRK -43% . Phathom Pharmaceutical...

NAUT - Nautilus Biotechnology GAAP EPS of -$0.12 beats by $0.05

Nautilus Biotechnology press release ( NASDAQ: NAUT ): Q2 GAAP EPS of -$0.12 beats by $0.05 . For further details see: Nautilus Biotechnology GAAP EPS of -$0.12 beats by $0.05

NAUT - Nautilus Biotechnology Reports Second Quarter 2022 Financial Results

SEATTLE, Aug. 02, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule proteome analysis, today reported financial results for the second quarter ended June 30, 2022. Recent Highlights ...
NAUT - Nautilus Biotechnology Appoints Eric Spence as Vice President of Instrument Engineering and Ken Kuhn, Ph.D., as Vice President of Reagent and Platform Development

SEATTLE, Aug. 01, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced further expansion of its management team with the appointments ...

NAUT - Nautilus Biotechnology Q2 2022 Earnings Preview

Nautilus Biotechnology ( NASDAQ: NAUT ) is scheduled to announce Q2 earnings results on Tuesday, August 2nd, before market open. The consensus EPS Estimate is -$0.17 (+10.5% Y/Y) and the consensus Revenue Estimate is $0M Over the last 3 months, EPS estimates have seen ...

NAUT - Nautilus Biotechnology to Announce Second Quarter 2022 Financial Results on August 2, 2022

SEATTLE, July 13, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced it will report financial results for the second quarter 20...
Previous 10 Next 10